Lenalidomide Therapy In Previously Untreated, Advanced Stage Indolent Lymphoma

Trial Profile

Lenalidomide Therapy In Previously Untreated, Advanced Stage Indolent Lymphoma

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 29 Sep 2015

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Follicular lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Sep 2015 Status changed from discontinued to withdrawn prior to enrolment,as reported by ClinicalTrials.gov.
    • 22 Sep 2015 Status changed from withdrawn prior to enrolment to discontinued as reported by ClinicalTrials.gov.
    • 05 Mar 2015 Planned End Date changed from 1 Aug 2012 to 1 May 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top